(2018). Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13482.
A. de Boer
(2018). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826.
(2018). Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013. Respir Med. http://doi.org/10.1016/j.rmed.2018.09.010.
(2018). Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13692.
(2019). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826.
(2019). Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database. J Am Geriatr Soc. http://doi.org/10.1111/jgs.16227.
(2019). Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists. Int J Clin Pharm. http://doi.org/10.1007/s11096-019-00916-1.
(2019). C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD. Pulm Pharmacol Ther. http://doi.org/10.1016/j.pupt.2019.101870.
(2020). Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14227.
(2020). Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5065.